𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liposomal daunorubicin in tumor stage cutaneous T-cell lymphoma

✍ Scribed by U. Wollina; K. Hohaus; J. Schönlebe; E. Haroske; E. Köstler


Book ID
106123227
Publisher
Springer-Verlag
Year
2003
Tongue
English
Weight
304 KB
Volume
129
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Multicenter study of pegylated liposomal
✍ Uwe Wollina; Reinhard Dummer; Norbert H. Brockmeyer; Helga Konrad; J.-O. Busch; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract ## BACKGROUND In single center studies and case reports, it was shown that pegylated liposomal doxorubicin (PEG‐DOXO) was effective as second‐line therapy for patients with cutaneous T‐cell lymphoma (CTCL). The objective of this study was to evaluate the efficacy and toxicity of single

DAB389IL2 diphtheria fusion toxin produc
✍ Duvic, Madeleine; Cather, Jennifer; Maize, John; Frankel, Arthur E. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Four patients with late stage cutaneous T cell lymphoma (IB-IVA) who had failed at least two previous therapies were treated with DAB 389 IL2 at 9 or 18 µg/kg as 15-min intravenous infusions daily for 5 days every 3 weeks for eight cycles. Mild vascular leak syndrome (VLS) with transient edema, hypo

Tumor-specific antigens in cutaneous T-c
✍ Stefan Eichmüller; Dirk Usener; Daniela Thiel; Dirk Schadendorf 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 142 KB 👁 1 views

## Abstract Cutaneous T‐cell lymphoma (CTCL) is a heterogeneous group of extra‐nodal non‐Hodgkin lymphomas with primary manifestation in the skin with poor treatment options in the advanced stages. As basis for future immune‐therapeutic strategies we have investigated the possible expression of tum